Identification of human cell responses to benzene and benzene metabolites

Genomics

Volumn 90, Issue 3, 2007, Pages 324-333

  Gillis, Bruce ^a   Gavin, Igor M ^a   Arbieva, Zarema ^a   King, Stephen T ^a   Jayaraman, Sundararajan ^b   Prabhakar, Bellur S ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

1,2,4 Benzenetriol; 1,4 Benzoquinone; Benzene; Catechol; Chemokines; Cytokines; Gene expression profiling; Hydroquinone; Immune response

Indexed keywords

1,2,4 BENZENETRIOL; 1,4 BENZOQUINONE; BENZENE; CATECHOL; CHEMOKINE; CYTOKINE; HYDROQUINONE; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION;

ANTI-INFLAMMATORY AGENTS; BENZENE; BENZOQUINONES; CATECHOLS; CELLS, CULTURED; CYTOKINES; GENE EXPRESSION PROFILING; HUMANS; HYDROQUINONES; INTERLEUKIN-10; LEUKOCYTES, MONONUCLEAR; MAP KINASE SIGNALING SYSTEM; MODELS, BIOLOGICAL; RNA;

EID: 34547394837     PISSN: 08887543     EISSN: 10898646     Source Type: Journal    
DOI: 10.1016/j.ygeno.2007.05.003     Document Type: Article

References (50)

1. Bayliss D.L., Chen C., Jarabek A., Sonawane B., and Valcovic L. Carcinogenic Effects of Benzene: an Update (1998), U.S. Environmental Protection Agency, Washington, DC
2. IARC. Benzene, Overall Evaluations of Carcinogenicity: an Updating of Selected IARC Monographs from Volumes 1 to 42 (1987), International Agency for Research on Cancer, Lyon
3. Snyder R. Benzene and leukemia. Crit. Rev. Toxicol. 32 (2002) 155-210
4. Snyder R. Xenobiotic metabolism and the mechanism(s) of benzene toxicity. Drug Metab. Rev. 36 (2004) 531-547
5. Smith M.T. The mechanism of benzene-induced leukemia: a hypothesis and speculations on the causes of leukemia. Environ. Health Perspect. 104 Suppl. 6 (1996) 1219-1225
6. Whysner J., Reddy M.V., Ross P.M., Mohan M., and Lax E.A. Genotoxicity of benzene and its metabolites. Mutat. Res. 566 (2004) 99-130
7. Aoyama K. Effects of benzene inhalation on lymphocyte subpopulations and immune response in mice. Toxicol. Appl. Pharmacol. 85 (1986) 92-101
8. Rothman N., Li G.L., Dosemeci M., Bechtold W.E., Marti G.E., Wang Y.Z., Linet M., Xi L.Q., Lu W., Smith M.T., Titenko-Holland N., Zhang L.P., Blot W., Yin S.N., and Hayes R.B. Hematotoxicity among Chinese workers heavily exposed to benzene. Am. J. Ind. Med. 29 (1996) 236-246
9. Farris G.M., Robinson S.N., Wong B.A., Wong V.A., Hahn W.P., and Shah R. Effects of benzene on splenic, thymic, and femoral lymphocytes in mice. Toxicology 118 (1997) 137-148
10. Rozen M.G., and Snyder C.A. Protracted exposure of C57BL/6 mice to 300 ppm benzene depresses B- and T-lymphocyte numbers and mitogen responses: evidence for thymic and bone marrow proliferation in response to the exposures. Toxicology 37 (1985) 13-26
11. Pfeifer R.W., and Irons R.D. Effect of benzene metabolites on phytohemagglutinin-stimulated lymphopoiesis in rat bone marrow. J. Reticuloendothel. Soc. 31 (1982) 155-170
12. Rozen M.G., Snyder C.A., and Albert R.E. Depressions in B-and T-lymphocyte mitogen-induced blastogenesis in mice exposed to low concentrations of benzene. Toxicol. Lett. 20 (1984) 343-349
13. Pfeifer R.W., and Irons R.D. Inhibition of lectin-stimulated lymphocyte agglutination and mitogenesis by hydroquinone: reactivity with intracellular sulfhydryl groups. Exp. Mol. Pathol. 35 (1981) 189-198
14. Laskin D.L., MacEachern L., and Snyder R. Activation of bone marrow phagocytes following benzene treatment of mice. Environ. Health Perspect. 82 (1989) 75-79
15. MacEachern L., and Laskin D.L. Increased production of tumor necrosis factor-α by bone marrow leukocytes following benzene treatment of mice. Toxicol. Appl. Pharmacol. 113 (1992) 260-266
16. MacEachern L., Snyder R., and Laskin D.L. Alterations in the morphology and functional activity of bone marrow phagocytes following benzene treatment of mice. Toxicol. Appl. Pharmacol. 117 (1992) 147-154
17. Klan M.J., Adams D.O., and Lewis J.G. Effects of exposure to benzene in vivo on the murine mononuclear phagocyte system. Toxicol. Appl. Pharmacol. 103 (1990) 198-205
18. Lewis J.G., Odom B., and Adams D.O. Toxic effects of benzene and benzene metabolites on mononuclear phagocytes. Toxicol. Appl. Pharmacol. 92 (1988) 246-254
19. Manning B.W., Adams D.O., and Lewis J.G. Effects of benzene metabolites on receptor-mediated phagocytosis and cytoskeletal integrity in mouse peritoneal macrophages. Toxicol. Appl. Pharmacol. 126 (1994) 214-223
20. Smith M.T., Vermeulen R., Li G., Zhang L., Lan Q., Hubbard A.E., Forrest M.S., McHale C., Zhao X., Gunn L., Shen M., Rappaport S.M., Yin S., Chanock S., and Rothman N. Use of 'omic' technologies to study humans exposed to benzene. Chem. Biol. Interact. 153-154 (2005) 123-127
21. Forrest M.S., Lan Q., Hubbard A.E., Zhang L., Vermeulen R., Zhao X., Li G., Wu Y.Y., Shen M., Yin S., Chanock S.J., Rothman N., and Smith M.T. Discovery of novel biomarkers by microarray analysis of peripheral blood mononuclear cell gene expression in benzene-exposed workers. Environ. Health Perspect. 113 (2005) 801-807
22. Benjamini Y., and Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc., Ser. B 57 (1995) 289-300
23. Gutala R.V., and Reddy P.H. The use of real-time PCR analysis in a gene expression study of Alzheimer's disease post-mortem brains. J. Neurosci. Methods 132 (2004) 101-107
24. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29 (2001) e45
25. Hopkins S.J. The pathophysiological role of cytokines. Leg. Med. (Tokyo) 5 Suppl. 1 (2003) S45-S57
26. Bironaite D., Siegel D., Moran J.L., Weksler B.B., and Ross D. Stimulation of endothelial IL-8 (eIL-8) production and apoptosis by phenolic metabolites of benzene in HL-60 cells and human bone marrow endothelial cells. Chem. Biol. Interact. 149 (2004) 177-188
27. Miyazawa M., Ito Y., Yoshida Y., Sakaguchi H., and Suzuki H. Phenotypic alterations and cytokine production in THP-1 cells in response to allergens. Toxicol. In Vitro 21 3 (2007) 428-437
28. Laskin J.D., Rao N.R., Punjabi C.J., Laskin D.L., and Synder R. Distinct actions of benzene and its metabolites on nitric oxide production by bone marrow leukocytes. J. Leukocyte Biol. 57 (1995) 422-426
29. Tsuchida T., and Sakane T. Intracellular activation signal requirements for the induction of IL-2 responsiveness in resting T cell subsets in humans. J. Immunol. 140 (1988) 3446-3449
30. Kurtzhals J.A., Kemp M., Poulsen L.K., Hansen M.B., Kharazmi A., and Theander T.G. Interleukin-4 and interferon-gamma production by Leishmania stimulated peripheral blood mononuclear cells from nonexposed individuals. Scand. J. Immunol. 41 (1995) 343-349
31. Jason J., and Larned J. Single-cell cytokine profiles in normal humans: comparison of flow cytometric reagents and stimulation protocols. J. Immunol. Methods 207 (1997) 13-22
32. + T cells and increases immunoglobulin E levels in antigen-primed mice. Immunology 106 (2002) 496-502
33. Kim E., Kang B.Y., and Kim T.S. Inhibition of interleukin-12 production in mouse macrophages by hydroquinone, a reactive metabolite of benzene, via suppression of nuclear factor-kappaB binding activity. Immunol. Lett. 99 (2005) 24-29
34. Ouyang Y., Virasch N., Hao P., Aubrey M.T., Mukerjee N., Bierer B.E., and Freed B.M. Suppression of human IL-1beta, IL-2, IFN-gamma, and TNF-alpha production by cigarette smoke extracts. J. Allergy Clin. Immunol. 106 (2000) 280-287
35. Geiselhart L.A., Christian T., Minnear F., and Freed B.M. The cigarette tar component p-benzoquinone blocks T-lymphocyte activation by inhibiting interleukin-2 production, but not CD25, ICAM-1, or LFA-1 expression. Toxicol. Appl. Pharmacol. 143 (1997) 30-36
36. Post G.B., and Snyder R. Effects of enzyme induction on microsomal benzene metabolism. J. Toxicol. Environ. Health 11 (1983) 811-825
37. Koop D.R., Laethem C.L., and Schnier G.G. Identification of ethanol-inducible P450 isozyme 3a (P450IIE1) as a benzene and phenol hydroxylase. Toxicol. Appl. Pharmacol. 98 (1989) 278-288
38. Snyder R., Chepiga T., Yang C.S., Thomas H., Platt K., and Oesch F. Benzene metabolism by reconstituted cytochromes P450 2B1 and 2E1 and its modulation by cytochrome b5, microsomal epoxide hydrolase, and glutathione transferases: evidence for an important role of microsomal epoxide hydrolase in the formation of hydroquinone. Toxicol. Appl. Pharmacol. 122 (1993) 172-181
39. Kawanishi S., Inoue S., and Kawanishi M. Human DNA damage induced by 1,2,4-benzenetriol, a benzene metabolite. Cancer Res. 49 (1989) 164-168
40. Zhang L., Robertson M.L., Kolachana P., Davison A.J., and Smith M.T. Benzene metabolite, 1,2,4-benzenetriol, induces micronuclei and oxidative DNA damage in human lymphocytes and HL60 cells. Environ. Mol. Mutagen. 21 (1993) 339-348
41. Li A.S., Bandy B., Tsang S., and Davison A.J. DNA breakage induced by 1,2,4-benzenetriol: relative contributions of oxygen-derived active species and transition metal ions. Free Radic. Biol. Med. 30 (2001) 943-956
42. Faiola B., Fuller E.S., Wong V.A., and Recio L. Gene expression profile in bone marrow and hematopoietic stem cells in mice exposed to inhaled benzene. Mutat. Res. 549 (2004) 195-212
43. Yoon B.I., Li G.X., Kitada K., Kawasaki Y., Igarashi K., Kodama Y., Inoue T., Kobayashi K., Kanno J., Kim D.Y., Inoue T., and Hirabayashi Y. Mechanisms of benzene-induced hematotoxicity and leukemogenicity: cDNA microarray analyses using mouse bone marrow tissue. Environ. Health Perspect. 111 (2003) 1411-1420
44. Faiola B., Fuller E.S., Wong V.A., Pluta L., Abernethy D.J., Rose J., and Recio L. Exposure of hematopoietic stem cells to benzene or 1,4-benzoquinone induces gender-specific gene expression. Stem Cells 22 (2004) 750-758
45. Noessner E., Gastpar R., Milani V., Brandl A., Hutzler P.J., Kuppner M.C., Roos M., Kremmer E., Asea A., Calderwood S.K., and Issels R.D. Tumor-derived heat shock protein 70 peptide complexes are cross-presented by human dendritic cells. J. Immunol. 169 (2002) 5424-5432
46. Kunisawa J., and Shastri N. Hsp90alpha chaperones large C-terminally extended proteolytic intermediates in the MHC class I antigen processing pathway. Immunity 24 (2006) 523-534
47. Sutter T.R., Tang Y.M., Hayes C.L., Wo Y.Y., Jabs E.W., Li X., Yin H., Cody C.W., and Greenlee W.F. Complete cDNA sequence of a human dioxin-inducible mRNA identifies a new gene subfamily of cytochrome P450 that maps to chromosome 2. J. Biol. Chem. 269 (1994) 13092-13099
48. Pikuleva I.A., Bjorkhem I., and Waterman M.R. Expression, purification, and enzymatic properties of recombinant human cytochrome P450c27 (CYP27). Arch. Biochem. Biophys. 343 (1997) 123-130
49. Coletti D., Yang E., Marazzi G., and Sassoon D. TNFalpha inhibits skeletal myogenesis through a PW1-dependent pathway by recruitment of caspase pathways. EMBO J. 21 (2002) 631-642
50. Boley S.E., Wong V.A., French J.E., and Recio L. p53 heterozygosity alters the mRNA expression of p53 target genes in the bone marrow in response to inhaled benzene. Toxicol. Sci. 66 (2002) 209-215